Chardan Capital Says to Buy Spark Therapeutics (ONCE) Peers Following SPK-RPE65 Results (AAVL) (VBLT)

Go back to Chardan Capital Says to Buy Spark Therapeutics (ONCE) Peers Following SPK-RPE65 Results (AAVL) (VBLT)

Form 8-K Spark Therapeutics, Inc. For: Oct 05

October 5, 2015 6:44 AM EDT


UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C.... More